Rejected at 2:25 a.m. Nov, 01, 2023 ] by Aaron
Author: mfahhoum
Related Note: 1462849123696 3
Rationale for change

characterized by intermediate action and duration

Rejection reason

please site source and resubmit

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#B&B::09_Endocrinology::03_Pancreas::05_Insulin_Medications #AK_Step1_v12::#Pixorize::03_Pharmacology::07_Diabetes_Drugs_(New)::04_Insulin_Preparations #AK_Step1_v12::#Physeo::09_Pharm::07_Endocrine::01_Insulin_Preparations #PANCE::EOR::PEDS #AK_Step1_v12::#UWorld::COMLEX::23713 #AK_Step2_v12::#SketchyIM::05_Endocrinology::01_Diabetes_Mellitus::02_Diabetes_Management #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#OME::04_Organ_Systems::06_Endocrine::05_Pancreas::03_Diabetes_Pharmacology #AK_Step1_v12::#UWorld::Step::850 #AK_Step2_v12::#FirstAid::03_Endocrinology::01_Disorders_of_Glucose_Metabolism::02_Diabetes_Mellitus #AK_Step1_v12::#Pixorize::03_Pharmacology::08_Diabetes_Drugs_(Old)::01_Insulin_Preparations #PANCE::ENDO::diabetes #AK_Step1_v12::^Systems::Endocrine::Pharmacology #AK_Step1_v12::#OME::PreClinical::04_Organ_Systems::06_Endocrine::05_Pancreas::03_Diabetes_Pharmacology #AK_Step1_v12::#UWorld::Step::600 #AK_Step1_v12::#FirstAid::08_Endocrine::05_Pharm::01_Diabetes_mellitus_therapy::*Insulin_Preparations::Short_Acting #AK_Step1_v12::#UWorld::COMLEX::23962 #AK_Step2_v12::#B&B::04_Endocrinology::03_Diabetes::04_Insulin #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::02_Diabetes::01_Insulin,_sulfonylureas,_meglitinides,_GLP-1_agonists,_DPP-4_inhibitors #AK_Step1_v12::#Bootcamp::Endocrinology::07_Pancreas::08_Diabetes_Type_I_Management